COVID-19: Developing Drugs and Biological Products for Treatment or Prevention - Background and New FDA Guidance
COVID-19 Panel Discussion: Navigating translational/early clinical development during COVID-19
tranScrip's Managing Partner, Dr Flic Gabbay, has been awarded the Fellowship of the Academy of Medical Sciences
tranScrip congratulates Synairgen on their continued dedication to combat COVID-19
Promising New Treatment for Recurrent Paediatric Brain Cancer
tranScrip welcomes the launch of the ACCORD clinical trials platform
Pan-tumour registration using a diagnostic - this time tumour mutational burden (TMB)
COVID-19 Pandemic: Another reason to give up smoking; the sooner, the better
COVID-19 Vaccine and Antiviral Drug Development
Chloroquine Conundrum: One size may not fit all in the COVID-19 treatment dilemma